Medicare’s Cannabis (CBD) Coverage Plan Sparks Federal Controversy
Medicare CBD policy access is a critical issue affecting patient care and clinical practice. Federal controversy surrounds cannabis coverage decisions by CMS. This debate impacts access for millions relying on Medicare.
Up in Smoke: Ohio Rolls Back Some Weed and Hemp Laws with New Restrictions
Ohio cannabis regulatory rollbacks are creating immediate clinical uncertainty around patient access to cannabis products. These changes particularly affect hemp-derived CBD and delta-8 THC formulations. Patients and clinicians must prepare for potential…
Expert: A CBD product ban is unnecessary if regulation is in place on all intoxicating compounds
Regulatory uncertainty around cbd regulation hemp products policy directly affects patient access to therapeutic compounds. Clear frameworks ensure product quality, dosing consistency, and safety. Experts argue that bans are unnecessary if comprehensive…
CBD And CBG From Cannabis May Help Treat Liver Condition
CBD CBG preclinical research NAFLD highlights promising cannabis compounds for fatty liver disease. These compounds may reduce liver inflammation and steatosis. This research could advance treatment options for NAFLD patients.
New York Approves Cannabis for Anxiety Despite Mixed Science
New York cannabis anxiety approval marks a significant policy change. However, clinical evidence for cannabis treating anxiety remains limited and mixed. Patients and clinicians face challenges navigating this new approval.
Unleashing Calm: A Complete Guide to Finding the Best CBD Gummies for Relaxation
CBD gummy health benefits are increasingly recognized for relaxation and anxiety support. This guide reviews clinical evidence and dosing considerations. Learn how to choose the best CBD gummies for your needs.
OCM Resumes Accepting Hemp Business License Applications
Minnesota's Office of Cannabis Management has resumed accepting hemp business license applications. This regulatory move aims to improve safety and consistency in hemp-derived therapeutics. Hemp business license applications are critical for ensuring…
Major Autism Study Tests Melbourne-Made Cannabis Oil on Children | Herald Sun
A new clinical trial is testing cannabinoid therapy pediatric autism using Melbourne-made cannabis oil. This study aims to provide high-quality data on safety and efficacy for children with autism spectrum disorder. The trial could offer important…
Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children
This study explores CBD autism social communication effects on anxiety and parental stress in autistic children. Findings suggest modest improvements in social relating and reduced parental stress. These preliminary results highlight potential benefits…
Trump Administration Announces New Medicare CBD Coverage Details
The Trump administration has released Medicare CBD coverage details that could affect cannabinoid reimbursement. This update signals federal recognition of cannabinoids in healthcare. Medicare coverage decisions will influence access to CBD therapies for…